Therapeutics handbook ggc




















Stoma care 1. Drugs affecting intestinal secretions 2. Cardiovascular system 2. Positive inotropic drugs 2. Diuretics 2. Anti-arrhythmic drugs 2. Beta-adrenoceptor blocking drugs 2. Hypertension and heart failure 2. Nitrates, calcium-channel blockers and other antianginal drugs 2. Sympathomimetics 2. Anticoagulants and protamine 2.

Antiplatelet drugs 2. Stable angina, acute coronary syndromes and fibrinolysis 2. Antifibrinolytic drugs and haemostatics 2. Lipid-regulating drugs 2. Local sclerosants 3. Respiratory system 3. Bronchodilators 3. Corticosteroids 3. Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inh 3. Antihistamines, hyposensitisation, and allergic emergencies 3. Respiratory stimulants and pulmonary surfactants 3. Oxygen 3.

Mucolytics 3. Aromatic inhalations 3. Cough preparations 3. Systemic nasal decongestants 3. Antifibrotics 4. Central nervous system 4. Hypnotics and anxiolytics 4. Drugs used in psychoses and related disorders 4. Antidepressant drugs 4. CNS stimulants and drugs used for attention deficit hyperactivity disorder 4. Drugs used in the treatment of obesity 4. Drugs used in nausea and vertigo 4. Analgesics 4. Antiepileptic drugs 4. Drugs used in parkinsonism and related disorders 4.

Drugs used in substance dependence 4. Drugs for dementia 5. Infections 5. Antibacterial drugs 5. Antifungal drugs 5. Antiviral drugs 5. Antiprotozoal drugs 5. Anthelmintics 6. Endocrine system 6. Drugs used in diabetes 6. Thyroid and antithyroid drugs 6. Larger doses may be required especially in patients with digitoxicity or diabetic ketoacidosis. Advice is available from the Biochemistry Department.

Caution should be used in patients with renal insufficiency or when Angiotensin-Converting Enzyme ACE inhibitors or potassium-sparing diuretics are being administered concomitantly. Intravenous potassium supplementation Intravenous supplements are indicated if patients cannot eat, are unlikely to absorb oral potassium or have profound hypokalaemia.

Antifibrinolytic drugs and haemostatics 2. Lipid-regulating drugs 2. Local sclerosants 3. Respiratory system 3. Bronchodilators 3. Corticosteroids 3. Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inh 3. Antihistamines, hyposensitisation, and allergic emergencies 3.

Respiratory stimulants and pulmonary surfactants 3. Oxygen 3. Mucolytics 3. Aromatic inhalations 3. Cough preparations 3. Systemic nasal decongestants 3.

Antifibrotics 4. Central nervous system 4. Hypnotics and anxiolytics 4. Drugs used in psychoses and related disorders 4. Antidepressant drugs 4. CNS stimulants and drugs used for attention deficit hyperactivity disorder 4. Drugs used in the treatment of obesity 4. Drugs used in nausea and vertigo 4. Analgesics 4. Antiepileptic drugs 4. Drugs used in parkinsonism and related disorders 4. Drugs used in substance dependence 4.

Drugs for dementia 5. Infections 5. Antibacterial drugs 5. Antifungal drugs 5. Antiviral drugs 5. Antiprotozoal drugs 5.

Anthelmintics 6. Endocrine system 6. Drugs used in diabetes 6. Thyroid and antithyroid drugs 6. Corticosteroids 6. Sex hormones 6. Hypothalamic and pituitary hormones and anti-oestrogens 6. Drugs affecting bone metabolism 6.

Other endocrine drugs 7.



0コメント

  • 1000 / 1000